Daejeon, South Korea

Jeong Su Byun

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeong Su Byun. Retrieved from https://idiyas.com/inventor/jeong-su-byun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jeong Su Byun: Innovator in Neurodegenerative Disease Treatment

Introduction

Jeong Su Byun is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative diseases. With a total of 3 patents to his name, Byun's work focuses on innovative compositions that aim to improve health outcomes for patients suffering from these debilitating conditions.

Latest Patents

Byun's latest patents include a composition for preventing or treating neurodegenerative diseases that contains a diterpene-based compound. This invention relates to a pharmaceutical composition that can prevent or treat neurodegenerative diseases by activating Nurr1 and inhibiting the inflammatory response. Another notable patent involves a pharmaceutical composition and health functional food that includes a flower extract as an active ingredient. This composition is designed to prevent or treat neurodegenerative diseases while being free from genotoxicity, showcasing superior prophylactic and treatment effects compared to traditional extracts.

Career Highlights

Jeong Su Byun is affiliated with the Korea Research Institute of Bioscience and Biotechnology, where he conducts his research and development. His work is characterized by a commitment to advancing medical science and improving therapeutic options for patients.

Collaborations

Byun collaborates with esteemed colleagues such as Won Gon Kim and Baek Soo Han, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Jeong Su Byun's contributions to the field of neurodegenerative disease treatment highlight his dedication to improving patient health through innovative pharmaceutical compositions. His work continues to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…